The authors describe a patient with the neuroleptic malignant syndrome
whose excessive catecholamine excretion indicates hyperactivity of the
sympathoadrenomedullary component of the autonomic nervous system. Their
finding provides a physiological basis for using catecholamine blocking
agents to treat some patients with this syndrome.Abstract Teaser